ClearPoint Neuro (CLPT) Cash from Financing Activities (2018 - 2026)
ClearPoint Neuro's Cash from Financing Activities history spans 12 years, with the latest figure at $19.6 million for Q4 2025.
- On a quarterly basis, Cash from Financing Activities rose 52775.68% to $19.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $50.2 million, a 710.78% increase, with the full-year FY2025 number at $50.2 million, up 710.78% from a year prior.
- Cash from Financing Activities hit $19.6 million in Q4 2025 for ClearPoint Neuro, down from $32.0 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for CLPT hit a ceiling of $46.9 million in Q1 2021 and a floor of -$10.1 million in Q3 2024.
- Historically, Cash from Financing Activities has averaged $5.5 million across 5 years, with a median of $155000.0 in 2023.
- The widest YoY moves for Cash from Financing Activities: up 321160.0% in 2024, down 10956.04% in 2024.
- Tracing CLPT's Cash from Financing Activities over 5 years: stood at $48000.0 in 2021, then surged by 362.5% to $222000.0 in 2022, then tumbled by 30.18% to $155000.0 in 2023, then crashed by 76.13% to $37000.0 in 2024, then skyrocketed by 52775.68% to $19.6 million in 2025.
- Business Quant data shows Cash from Financing Activities for CLPT at $19.6 million in Q4 2025, $32.0 million in Q2 2025, and -$1.4 million in Q1 2025.